本頁面由Tiger Trade Technology Pte. Ltd.提供服務

AEON Biopharma

0.2043
+0.00693.50%
成交量:3,906.53萬
成交額:994.72萬
市值:1,019.11萬
市盈率:-0.06
高:0.3296
開:0.2029
低:0.1900
收:0.1974
52周最高:1.45
52周最低:0.1772
股本:4,988.28萬
流通股本:3,050.95萬
量比:7.11
換手率:128.04%
股息:- -
股息率:- -
每股收益(TTM):-3.5840
每股收益(LYR):-3.9532
淨資產收益率:--
總資產收益率:-141.53%
市淨率:-0.66
市盈率(LYR):-0.05

資料載入中...

2024/07/23

SEC問詢函

Form CORRESP - Correspondence
2024/07/09

SEC問詢函

Form CORRESP - Correspondence
2024/07/09

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/31

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/31

SEC問詢函

Form CORRESP - Correspondence
2024/05/16

重要事件披露

Form 8-K - Current report
2024/05/14

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/24

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/10/23

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/19

重要事件披露

Form 8-K - Current report
2023/10/03

重要事件披露

Form 8-K - Current report
2023/08/23

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/14

重要事件披露

Form 8-K/A - Current report: [Amend]
2023/08/01

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership